Kousuke Tani

1.3k total citations
22 papers, 1.1k citations indexed

About

Kousuke Tani is a scholar working on Organic Chemistry, Pharmacology and Genetics. According to data from OpenAlex, Kousuke Tani has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 11 papers in Pharmacology and 4 papers in Genetics. Recurrent topics in Kousuke Tani's work include Inflammatory mediators and NSAID effects (11 papers), Asymmetric Synthesis and Catalysis (6 papers) and Estrogen and related hormone effects (4 papers). Kousuke Tani is often cited by papers focused on Inflammatory mediators and NSAID effects (11 papers), Asymmetric Synthesis and Catalysis (6 papers) and Estrogen and related hormone effects (4 papers). Kousuke Tani collaborates with scholars based in Japan, United States and United Kingdom. Kousuke Tani's co-authors include Brian M. Stoltz, Douglas C. Behenna, Ryan M. L. McFadden, Takayuki Maruyama, Shuichi Ohuchida, Michiyoshi Kobayashi, Tomohiro Kitamura, Keiji Wakabayashi, Kaoru Kobayashi and Takashi Sügimura and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Chemistry - A European Journal.

In The Last Decade

Kousuke Tani

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kousuke Tani Japan 13 631 389 276 195 186 22 1.1k
Hélène Jûteau Canada 13 654 1.0× 522 1.3× 346 1.3× 51 0.3× 158 0.8× 22 1.4k
Torsten Knieß Germany 23 538 0.9× 252 0.6× 429 1.6× 65 0.3× 95 0.5× 83 1.4k
François Carreaux France 26 1.4k 2.3× 123 0.3× 858 3.1× 198 1.0× 88 0.5× 90 2.0k
Adrian Hall United Kingdom 24 1.0k 1.6× 257 0.7× 414 1.5× 84 0.4× 27 0.1× 62 1.5k
David B. Reitz United States 21 1.1k 1.7× 293 0.8× 529 1.9× 90 0.5× 102 0.5× 42 1.5k
Eugene J. Trybulski United States 19 698 1.1× 107 0.3× 384 1.4× 78 0.4× 112 0.6× 52 1.1k
Marc B. Skaddan United States 14 218 0.3× 87 0.2× 234 0.8× 211 1.1× 83 0.4× 23 816
David F. McComsey United States 28 983 1.6× 124 0.3× 648 2.3× 84 0.4× 18 0.1× 64 1.9k
Aaron Balog United States 25 1.4k 2.2× 331 0.9× 708 2.6× 71 0.4× 116 0.6× 50 2.4k
S. David Kimball United States 25 1.7k 2.7× 220 0.6× 802 2.9× 69 0.4× 47 0.3× 50 2.6k

Countries citing papers authored by Kousuke Tani

Since Specialization
Citations

This map shows the geographic impact of Kousuke Tani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kousuke Tani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kousuke Tani more than expected).

Fields of papers citing papers by Kousuke Tani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kousuke Tani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kousuke Tani. The network helps show where Kousuke Tani may publish in the future.

Co-authorship network of co-authors of Kousuke Tani

This figure shows the co-authorship network connecting the top 25 collaborators of Kousuke Tani. A scholar is included among the top collaborators of Kousuke Tani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kousuke Tani. Kousuke Tani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ogawa, Seiji, Toshihide Watanabe, Isamu Sugimoto, et al.. (2016). Discovery of G Protein-Biased EP2 Receptor Agonists. ACS Medicinal Chemistry Letters. 7(3). 306–311. 11 indexed citations
2.
Ogawa, Seiji, Toshihide Watanabe, Yoshikazu Goto, et al.. (2016). Structural optimization and structure–functional selectivity relationship studies of G protein-biased EP2 receptor agonists. Bioorganic & Medicinal Chemistry Letters. 26(10). 2446–2449. 6 indexed citations
3.
Sugimoto, Isamu, Tetsuo Obitsu, Taihei Nishiyama, et al.. (2016). Discovery of Novel Seven-Membered Prostacyclin Analogues as Potent and Selective Prostaglandin FP and EP3 Dual Agonists. ACS Medicinal Chemistry Letters. 8(1). 107–112. 1 indexed citations
4.
Behenna, Douglas C., Justin T. Mohr, Nathaniel H. Sherden, et al.. (2011). Enantioselective Decarboxylative Alkylation Reactions: Catalyst Development, Substrate Scope, and Mechanistic Studies. Chemistry - A European Journal. 17(50). 14199–14223. 171 indexed citations
5.
Naganawa, Atsushi, Atsushi Kinoshita, Seiji Ogawa, et al.. (2011). Discovery of new orally active prostaglandin D2 receptor antagonists. Bioorganic & Medicinal Chemistry. 19(22). 6935–6948. 3 indexed citations
6.
Tani, Kousuke, Douglas C. Behenna, Ryan M. L. McFadden, & Brian M. Stoltz. (2007). A Facile and Modular Synthesis of Phosphinooxazoline Ligands. Organic Letters. 9(13). 2529–2531. 98 indexed citations
7.
Tani, Kousuke & Brian M. Stoltz. (2006). Synthesis and structural analysis of 2-quinuclidonium tetrafluoroborate. Nature. 441(7094). 731–734. 231 indexed citations
8.
Kitamura, Tomohiro, Masaki Itoh, Tetsuo Noda, et al.. (2003). Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice. Cancer Science. 94(7). 618–621. 42 indexed citations
9.
Tani, Kousuke, Atsushi Naganawa, Kenji Sagawa, et al.. (2002). Development of a highly selective EP2-receptor agonist. Part 2: identification of 16-Hydroxy-17,17-trimethylene 9β-chloro PGF derivatives. Bioorganic & Medicinal Chemistry. 10(4). 1107–1114. 13 indexed citations
10.
Tani, Kousuke, Atsushi Naganawa, Kenji Sagawa, et al.. (2002). Development of a highly selective EP2-receptor agonist. Part 1: identification of 16-hydroxy-17,17-trimethylene PGE2 derivatives. Bioorganic & Medicinal Chemistry. 10(4). 1093–1106. 16 indexed citations
11.
Tani, Kousuke. (2002). A Practical Synthesis and Biological Evaluation of 9-Halogenated PGF Analogues. Bioorganic & Medicinal Chemistry. 10(6). 1883–1894. 5 indexed citations
12.
Tani, Kousuke, Atsushi Naganawa, Yoshihiko Odagaki, et al.. (2002). Synthesis of a Highly Selective EP2-Receptor Agonist. Synlett. 2002(2). 239–242. 2 indexed citations
13.
Tani, Kousuke, Atsushi Naganawa, Kenji Sagawa, et al.. (2001). Design and Synthesis of a Highly Selective EP2-Receptor Agonist. Bioorganic & Medicinal Chemistry Letters. 11(15). 2025–2028. 37 indexed citations
14.
Yamamoto, Hiroshi, Takayuki Maruyama, Kiyoto Sakata, et al.. (1999). Novel four selective agonists for prostaglandin E receptor subtypes. Prostaglandins & Other Lipid Mediators. 59(1-6). 150–150. 22 indexed citations
15.
Kameo, Kazuya, et al.. (1998). Synthesis and pharmacological activities of 13-Dehydro derivatives of primary prostaglandins. Bioorganic & Medicinal Chemistry Letters. 8(12). 1507–1510. 5 indexed citations
16.
Okamoto, Sentaro, et al.. (1994). Conversion of allyl alk-2-ynoates to alk-2-ynoic acids using morpholine and palladium(0)-bis(diphenylphosphino)alkane catalyst; synthesis of 2,2,3,3-tetradehydro PGE1. Journal of the Chemical Society Chemical Communications. 279–279. 12 indexed citations
17.
Okamoto, Sentaro, Kousuke Tani, Fumie Sato, K. Barry Sharpless, & Davit Zargarian. (1993). Synthesis of optically active secondary allylic alcohols from allylsilanes via successive asymmetric dihydroxylation (AD) and Peterson olefination reactions. Tetrahedron Letters. 34(15). 2509–2512. 11 indexed citations
18.
Tani, Kousuke, et al.. (1993). Palladiurn(0)-catalysed transfer hydrogenation of alkynes to cis-alkenes with HCO2H–NEt3. Journal of the Chemical Society Chemical Communications. 386–387. 39 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hélène Jûteau Breakdown of academic impact, for papers by Torsten Knieß Breakdown of academic impact, for papers by François Carreaux Breakdown of academic impact, for papers by Adrian Hall Breakdown of academic impact, for papers by David B. Reitz Breakdown of academic impact, for papers by Eugene J. Trybulski Breakdown of academic impact, for papers by Marc B. Skaddan Breakdown of academic impact, for papers by David F. McComsey Breakdown of academic impact, for papers by Aaron Balog Breakdown of academic impact, for papers by S. David Kimball
Rankless by CCL
2026